Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6401
ProShares Ultra Technology
ROM
$1.33B
| $3K | ﹤0.01% |
+64
| New | +$4.18K |
|
6402
Scilex Holding
SCLX
$47.4M
| $3K | ﹤0.01% |
383
+366
| +2,153% | +$4.6K |
|
6403
Comscore
SCOR
$91.6M
| $3K | ﹤0.01% |
+500
| New | +$3.34K |
|
6404
374Water
SCWO
$44.6M
| $3K | ﹤0.01% |
837
+460
| +122% | +$2.03K |
|
|
SGMO
6405
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3K | ﹤0.01% |
5,006
+1,354
| +37% | +$1.43K |
|
6406
Star Group
SGU
$411M
| $3K | ﹤0.01% |
259
-320
| -55% | -$4K |
|
6407
Silicom
SILC
$258M
| $3K | ﹤0.01% |
173
+105
| +154% | +$1.71K |
|
|
FIRY
6408
Firy Inc
FIRY
$158M
| $3K | ﹤0.01% |
680
-2,645
| -80% | -$15.1K |
|
6409
Soluna Holdings
SLNH
$205M
| $3K | ﹤0.01% |
+4,000
| New | +$6.19K |
|
|
SOL
6410
DELISTED
Emeren Group
SOL
| $3K | ﹤0.01% |
1,677
-210
| -11% | -$367 |
|
6411
Scholar Rock
SRRK
$6.46B
| $3K | ﹤0.01% |
105
-2,370
| -96% | -$91.2K |
|
6412
Value Line
VALU
$341M
| $3K | ﹤0.01% |
88
+45
| +105% | +$1.85K |
|
6413
VinFast Auto
VFS
$7.37B
| $3K | ﹤0.01% |
965
| – | – |
|
6414
Viridian Therapeutics
VRDN
$2.49B
| $3K | ﹤0.01% |
213
-3,436
| -94% | -$58.5K |
|
6415
Xponential Fitness
XPOF
$206M
| $3K | ﹤0.01% |
459
-735
| -62% | -$10.2K |
|
6416
ZipRecruiter
ZIP
$388M
| $3K | ﹤0.01% |
355
-1,378
| -80% | -$9.19K |
|
6417
ArriVent BioPharma
AVBP
$1.4B
| $3K | ﹤0.01% |
144
-1,608
| -92% | -$39.4K |
|
6418
Q32 Bio
QTTB
$458M
| $3K | ﹤0.01% |
1,688
+305
| +22% | +$821 |
|
6419
Skye Bioscience
SKYE
$19M
| $3K | ﹤0.01% |
1,840
-1,759
| -49% | -$4.8K |
|
|
QIG
6420
WisdomTree U.S. Corporate Bond Fund
QIG
$17.5M
| $3K | ﹤0.01% |
+63
| New | +$2.78K |
|
|
MSLC
6421
Morgan Stanley Pathway Large Cap Equity ETF
MSLC
$4.13B
| $3K | ﹤0.01% |
58
-507
| -90% | -$24.5K |
|
|
TJGC
6422
TJGC Group Limited Class A Ordinary Shares
TJGC
$39M
| $3K | ﹤0.01% |
+142
| New | +$2.44K |
|
|
DM
6423
DELISTED
Desktop Metal, Inc.
DM
| $3K | ﹤0.01% |
678
+367
| +118% | +$950 |
|
|
VCSA
6424
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $3K | ﹤0.01% |
611
-1,455
| -70% | -$7.52K |
|
6425
Acrivon Therapeutics
ACRV
$79.2M
| $2K | ﹤0.01% |
849
-789
| -48% | -$4.25K |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.